Carbiotix (CRBX.ST) Stock Analysis & AI Equity Report
Carbiotix (CRBX.ST) overview
Carbiotix (CRBX.ST) stock analysis and AI equity research. For the latest completed financial year, 2024, Carbiotix reported revenue of SEK 1.0m and operating profit of SEK -16.0m; the year-end share price was 11.65 SEK and market capitalisation was SEK 43.8m. Carbiotix is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Carbiotix's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2025-09-29. Data will be refreshed during report generation.
About Carbiotix
Carbiotix AB is a Swedish biotechnology company focused on the onsite upcycling of plant-based side-streams. Its NutraCycle service helps food, beverage, ingredient and feed producers convert by-products into fortified ingredients and other higher-value outputs. The company previously developed prebiotic ingredients and microbiome diagnostics, but has since centered on NutraCycle.
Generate the Carbiotix report
Carbiotix is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Carbiotix and represent the latest completed financial year (2024). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.